Organisation paid for research Program year 2025 Source: CMS Open Payments

Research Foundation for SUNY

Neither a doctor nor a teaching hospital

Research payments

$639,118

252 payments

Through program year 2025, Research Foundation for SUNY is reported as receiving $639,118 in research payments, across 252 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $16,650 3
2024 Research $25,406 14
2023 Research $54,624 23
2022 Research $162,623 58
2021 Research $176,610 107
2020 Research $58,922 11
2019 Research $144,282 36

Breakdown

Who paid Research payments · program years 2019–2025
  1. Penumbra, Inc. $388,367 162 payments
  2. MIVI Neuroscience, Inc. $49,554 9 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $36,030 6 payments
  4. Genentech, Inc. $34,662 2 payments
  5. Arcutis Biotherapeutics, Inc. $31,741 16 payments
  6. Monteris Medical Corporation $31,187 16 payments
  7. Pfizer Inc. $24,320 18 payments
  8. AbbVie, Inc. $18,658 17 payments
  9. GlaxoSmithKline, LLC. $13,199 5 payments
  10. AstraZeneca Pharmaceuticals LP $11,400 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Mind $236,664 92 payments
  2. Insight $69,316 38 payments
  3. EvaQ IDE Study $44,265 7 payments
  4. Laantern $31,187 16 payments
  5. Strike-Pe $26,045 11 payments
  6. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Healthy Infants $24,320 18 payments
  7. A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) $22,530 4 payments
  8. Surf $20,200 5 payments
  9. Study to Investigate Safety and Efficiacy of Obinutuzumab in Patients With Sle $19,787 1 payment
  10. Randomised Double Blind Study to Evaluate Safety and Efficacy of Obinutuzumab in Class III and IV LN $14,875 1 payment
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $38,675 3 payments
  2. Other $2,000 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record